181 related articles for article (PubMed ID: 4152781)
1. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
Rodt H; Thierfelder S; Eulitz M
Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
[No Abstract] [Full Text] [Related]
2. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
Rodt H; Therfelder S; Eulitz M
Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
[No Abstract] [Full Text] [Related]
3. In vivo activity of cytotoxic lymphocytes.
Cerottini JC; Freedman LR; Brunner KT
Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
[No Abstract] [Full Text] [Related]
4. Adaptive phenomena in bone marrow transplantation.
Goujet-Zalc C; Ilbery PL
Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
[No Abstract] [Full Text] [Related]
5. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
Lonai P; Mogilner B; Rotter V; Trainin N
Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
[No Abstract] [Full Text] [Related]
6. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
Richie ER; Gallagher MT; Trentin JJ
Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
[No Abstract] [Full Text] [Related]
7. Mouse bone marrow lymphocytes and their differentiation.
Ryser JE; Vassalli P
J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
[No Abstract] [Full Text] [Related]
8. [Effects of a heterologous immune serum against bone marrow cells of the mouse].
von Broen B
Acta Biol Med Ger; 1974; 32(6):681-90. PubMed ID: 4153702
[No Abstract] [Full Text] [Related]
9. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
[TBL] [Abstract][Full Text] [Related]
10. [Use of heterologous antireceptor antibodies for specific reversal of acute homologous disease in mice].
Nesterenko VG; Gruner Sh; Rubakova EI; Babadzhanov AS
Biull Eksp Biol Med; 1980 Nov; 90(11):588-90. PubMed ID: 7192584
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the immune response. X. Antigen-antibody complex inactivation of cells involved in adoptive transfer.
Sinclair NR; Lees RK; Abrahams S; Chan PL; Fagan G; Stiller CR
J Immunol; 1974 Nov; 113(5):1493-500. PubMed ID: 4608468
[No Abstract] [Full Text] [Related]
12. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
Kinnamon KE; Blackwell LH; Ledney GD
Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
[No Abstract] [Full Text] [Related]
13. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
Thierfelder S; Rodt H
Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxic lymphocytes and anti-tumor immunity].
Cerottini JC; Brunner KT
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
[No Abstract] [Full Text] [Related]
15. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
Freedman LR; Cerottini JC; Brunner KT
J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
[No Abstract] [Full Text] [Related]
16. Suppression of acute secondary disease by heterologous anti-brain serum.
Rodt HV; Thierfelder S; Eulitz M
Blut; 1972 Dec; 25(6):385-9. PubMed ID: 4641722
[No Abstract] [Full Text] [Related]
17. Interaction of anti-thymocyte serum with hematopoietic stem cells. I. Effects in vitro and in vivo.
Mookerjee BK; Azzolina L; Poultar L
J Immunol; 1974 Feb; 112(2):822-9. PubMed ID: 4149885
[No Abstract] [Full Text] [Related]
18. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
Trentin JJ; Judd KP
Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
[No Abstract] [Full Text] [Related]
20. Significance of antigen binding by T cells.
Charreire J; Bach JF
Transplant Proc; 1973 Dec; 5(4):1735-7. PubMed ID: 4130079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
